Adjuvant Therapy for Incremental Low-Density Lipoprotein Cholesterol Reduction With Ezetimibe
نویسندگان
چکیده
منابع مشابه
Impact of Oxidized Low Density Lipoprotein Cholesterol under Ezetimibe or Rosuvastatin Therapy on Endothelial Function
Results: At baseline, MDA-LDL was inversely correlated with FMD (r=-0.565, p<0.05). MDA-LDL and FMD were improved in both groups (MDA-LDL: E; pre 155.7±73.8mg/dl, post 120.6±46.4mg/dl, p<0.05, R; pre 148.7±48.2mg/dl, post 104.2±28.9mg/dl, p<0.05), (FMD: E; pre 4.9±3.1%, post 7.6±2.5%, p<0.05, R; pre 4.3±1.8%, post 7.6±3.0%, p<0.01). Although the improvement of LDL was better in rosuvastatin gro...
متن کاملClinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
OBJECTIVES We sought to evaluate the significance of high-density lipoprotein cholesterol (HDL-C) in the context of low low-density lipoprotein cholesterol (LDL-C). BACKGROUND Earlier studies support an inverse correlation between circulating HDL-C and coronary risk in patients with normal or elevated LDL-C. METHODS This study involved 4,188 patients attending the Palo Alto Veterans Adminis...
متن کاملcholesterol/high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, non–high-density lipoprotein cholesterol, or low-density lipoprotein particle concentration and guideline categories of low-density lipoprotein cholesterol or non–high-density lipoprotein cholesterol
International clinical practice guidelines on dyslipidemia emphasize the importance of matching the use and intensity of statin therapy with the absolute risk of atherosclerotic cardiovascular disease (CVD). Indeed, independent of the baseline level of dyslipidemia, patients who have entered the intervention arms of randomized clinical trials of statin therapy with similar absolute risks of CVD...
متن کاملBeyond Low-Density Lipoprotein Cholesterol
Recent clinical trials in patients with coronary artery disease (CAD) provide evidence that low-density lipoprotein cholesterol (LDL-C) levels should be lowered even further to prevent recurrent CAD. However, despite more aggressive interventions for lowering LDL-C levels, the majority of CAD events go undeterred, perhaps related to the fact that intervention was not started earlier in life or ...
متن کاملHigh -density lipoprotein cholesterol as a predictor for diabetes mellitus
Background: Diabetes is a prevalent chronic disease around the world. To evaluate risk of diabetes comprehensively, we developed a score model for the risk prediction with HDL-C as a protective factor. Methods: We extracted physical examination data of 2728 individuals. The data contain 18 demographic and clinical variables. To identify the statistical significant feature variables, the backwa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Medicine Insights: Therapeutics
سال: 2017
ISSN: 1179-559X,1179-559X
DOI: 10.1177/1179559x17695550